Benefix
NDC Package 58394-003-06

The code 58394-003-06 identifies a specific commercial package of 1 kit in 1 carton * 5 ml in 1 syringe (58394-020-01) * 1 ml in 1 packet * 5 ml in 1 vial, single-use (58394-103-06) of Benefix, labeled by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc.. This is formulated for use and contains as the active substance.

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc. on February 01, 1997. The current certification is valid through September 18, 2015.

This medication is used to prevent or control bleeding in people with little or no factor IX (due to hemophilia B, Christmas disease). Factor IX is a protein (clotting factor) in the blood that works with other clotting factors to help the blood clot and therefore stop bleeding. People with little or no factor IX are at risk for bleeding longer after an injury/surgery or bleeding suddenly (often in the joints/muscle) without an obvious cause. This medication should not be used to treat other types of factor deficiencies (e.g., factors II, VII, VIII, X) or factor problems (e.g., inhibitor to factor XIII), to reverse the effects of "blood thinners" (e.g., warfarin), or to treat bleeding from low levels of liver-dependent clotting factors (due to liver problems).

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58394000306. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.